BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16472712)

  • 1. Role of Gemcitabine in Breast Cancer Management: An Update.
    Wirk B; Perez E
    Semin Oncol; 2006 Feb; 33(Suppl 2):S6-14. PubMed ID: 16472712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation.
    Takeda AL; Jones J; Loveman E; Tan SC; Clegg AJ
    Health Technol Assess; 2007 May; 11(19):iii, ix-xi, 1-62. PubMed ID: 17462169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
    Heinemann V
    Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine in the management of metastatic breast cancer: a systematic review.
    Dent S; Messersmith H; Trudeau M
    Breast Cancer Res Treat; 2008 Apr; 108(3):319-31. PubMed ID: 17530427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine and targeted therapy in metastatic breast cancer.
    Qu G; Perez EA
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):44-52. PubMed ID: 12138397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
    Cinieri S; Chan A; Altundag K; Vandebroek A; Tubiana-Mathieu N; Barnadas A; Dodyk P; Lazzarelli S; Botha M; Rauch D; Villanova G; Coskun U
    Clin Breast Cancer; 2017 Apr; 17(2):91-99.e1. PubMed ID: 27756583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the best schedule for administration of gemcitabine-taxane?
    Colomer R
    Cancer Treat Rev; 2005; 31 Suppl 4():S23-8. PubMed ID: 16360544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine and paclitaxel in metastatic breast cancer: a review.
    Colomer R
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 12):8-12. PubMed ID: 15685819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine in metastatic breast cancer.
    Heinemann V
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):429-43. PubMed ID: 16001951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer.
    Zielinski CC
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):36-40. PubMed ID: 14768404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
    O'Shaughnessy J
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of gemcitabine activity in advanced breast cancer.
    Smith IE
    Semin Oncol; 2006 Jun; 33(3 Suppl 9):S19-23. PubMed ID: 16797378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.
    Demiray M; Kurt E; Evrensel T; Kanat O; Arslan M; Saraydaroglu O; Ercan I; Gonullu G; Gokgoz S; Topal U; Tolunay S; Tasdelen I; Manavoglu O
    Cancer Invest; 2005; 23(5):386-91. PubMed ID: 16193637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gemcitabine and breast cancer].
    Besse B; Spano JP
    Bull Cancer; 2002 Aug; 89 Spec No():S107-14. PubMed ID: 12449040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.
    Park YH; Im SA; Kim SB; Sohn JH; Lee KS; Chae YS; Lee KH; Kim JH; Im YH; Kim JY; Kim TY; Lee KH; Ahn JH; Kim GM; Park IH; Lee SJ; Han HS; Kim SH; Jung KH;
    Eur J Cancer; 2017 Nov; 86():385-393. PubMed ID: 29100193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metastatic breast cancer: new chemotherapy regimens with taxanes].
    Lopez M
    Clin Ter; 2005; 156(6):311-5. PubMed ID: 16463568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma].
    Longo F; Mansueto G
    Tumori; 2004; 90(5):1-8. PubMed ID: 15656346
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of gemcitabine in metastatic breast cancer patients: a short review.
    Silvestris N; Cinieri S; La Torre I; Pezzella G; Numico G; Orlando L; Lorusso V
    Breast; 2008 Jun; 17(3):220-6. PubMed ID: 18037292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of gemcitabine in treatment of metastatic breast cancer].
    Latipova DKh; Semiglazova TIu; Filatova LV; Gershanovich ML
    Vopr Onkol; 2011; 57(2):139-46. PubMed ID: 21809657
    [No Abstract]   [Full Text] [Related]  

  • 20. Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanes.
    Perez EA
    Clin Breast Cancer; 2004 Jan; 4 Suppl 3():S113-6. PubMed ID: 14754468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.